1,605 results on '"De Deyn, Peter P"'
Search Results
152. Associating Alzheimer’s disease pathology with its cerebrospinal fluid biomarkers
153. Plasma 5‐HIAA activity indicative of serotonergic disturbances in cognitively impaired, elderly patients experiencing postoperative delirium
154. De BPSD-DS evaluatieschaal voor dementiegerelateerde gedragsveranderingen bij mensen met downsyndroom (BPSD-DS II): optimalisatie en verdere validatie
155. Evidence for the existence of a communication between the eye and the brain?
156. DNMBP is genetically associated with Alzheimer dementia in the Belgian population
157. Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort
158. Association of Cerebrospinal Fluid Prion Protein Levels and the Distinction Between Alzheimer Disease and Creutzfeldt-Jakob Disease
159. Intracranial pressure fluctuations: a potential risk factor for glaucoma?
160. Reproducibility and clinical relevance of quantitative EEG parameters in cerebral ischemia: A basic approach
161. Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients
162. Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS
163. No correlation between time-linked plasma and CSF Aβ levels
164. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau 181P
165. Clinical and biochemical diagnosis of small-vessel disease in acute ischemic stroke
166. Foreign accent syndrome as a developmental motor speech disorder
167. Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS)
168. Microtubule associated protein tau p.R406W patient carriers present with a nonconforming clinical phenotype.
169. Mastication Dyspraxia: A Neurodevelopmental Disorder Reflecting Disruption of the Cerebellocerebral Network Involved in Planned Actions
170. The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation
171. How well do people living with neurodegenerative diseases manage their finances? A meta-analysis and systematic review on the capacity to make financial decisions in people living with neurodegenerative diseases
172. Extensive Genetic And Phenotypic Description Of MAPT p.R406W In The Flanders-Belgian Population
173. The genetics and neuropathology of frontotemporal lobar degeneration
174. Serum Glutamine Synthetase Has No Value as a Diagnostic Biomarker for Alzheimer’s Disease
175. Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia
176. Cerebellar neurocognition: Insights into the bottom of the brain
177. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia
178. Cerebellar cognitive affective syndrome without global mental retardation in two relatives with Gillespie syndrome
179. Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA
180. Developmental Coordination Disorder: Disruption of the Cerebello-Cerebral Network evidenced by SPECT
181. The Role of Tryptophan Catabolism along the Kynurenine Pathway in Acute Ischemic Stroke
182. Dimethylarginine Levels in Cerebrospinal Fluid of Hyperacute Ischemic Stroke Patients are Associated with Stroke Severity
183. The neglected puzzle of dementia in people with severe/profound intellectual disabilities: A systematic literature review of observable symptoms
184. Serum Corticosterone and Insulin Resistance as Early Biomarkers in the hAPP23 Overexpressing Mouse Model of Alzheimer’s Disease
185. Cognitive evaluation of disease-modifying efficacy of donepezil in the APP23 mouse model for Alzheimer’s disease
186. Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson’s Disease Dementia: A Retrospective Analysis of a Double-Blind Trial and an Open-Label Extension
187. Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium study
188. Association study of cholesterol-related genes in Alzheimer’s disease
189. A family‐based genetic study identifies mutations in TLR9 impairing receptor activation
190. Premature termination codon mutations in ABCA7 contribute to Alzheimer's disease risk in Belgian patients.
191. Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia
192. Neurobehavioral alterations in an adolescent following posterior fossa tumor resection
193. Risperidone for the Treatment of Neuropsychiatric Features in Dementia
194. Postoperative motor speech production in children with the syndrome of ‘cerebellar’ mutism and subsequent dysarthria: A critical review of the literature
195. Epileptic fits and epilepsy in the elderly: General reflections, specific issues and therapeutic implications
196. Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model
197. A plea for the elective inclusion of the brain in routine whole-body FDG PET
198. Extensive Genetic And Phenotypic Description Of MAPT p.R406W In The Flanders-Belgian Population (4248)
199. Amyloid burden quantification depends on PET and MR image processing methodology
200. The Anaesthetic Biobank of Cerebrospinal fluid: a unique repository for neuroscientific biomarker research
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.